Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Suppressive antibiotic therapy in prosthetic joint infections: A multicentre cohort study.

Escudero-Sanchez R, Senneville E, Digumber M, Soriano A, Dolores Del Toro M, Bahamonde A, Luis Del Pozo J, Guio L, Murillo O, Rico A, García-País MJ, Rodríguez-Pardo D, Iribarren JA, Fernández M, Benito N, Fresco G, García AM, Ariza J, Cobo J.

Clin Microbiol Infect. 2019 Sep 17. pii: S1198-743X(19)30492-6. doi: 10.1016/j.cmi.2019.09.007. [Epub ahead of print]

PMID:
31539638
2.

Vancomycin-Gentamicin Prefabricated Spacers in 2-Stage Revision Arthroplasty for Chronic Hip and Knee Periprosthetic Joint Infection: Insights Into Reimplantation Microbiology and Outcomes.

Corró S, Vicente M, Rodríguez-Pardo D, Pigrau C, Lung M, Corona PS.

J Arthroplasty. 2019 Aug 19. pii: S0883-5403(19)30727-2. doi: 10.1016/j.arth.2019.07.043. [Epub ahead of print]

PMID:
31530462
3.

Antibiotic prophylaxis in orthopaedic surgery: Clinical practice guidelines or individualized prophylaxis?

Rodríguez-Pardo D.

Enferm Infecc Microbiol Clin. 2019 Jul 31. pii: S0213-005X(19)30199-5. doi: 10.1016/j.eimc.2019.06.006. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31377036
4.

The Different Microbial Etiology of Prosthetic Joint Infections according to Route of Acquisition and Time after Prosthesis Implantation, Including the Role of Multidrug-Resistant Organisms.

Benito N, Mur I, Ribera A, Soriano A, Rodríguez-Pardo D, Sorlí L, Cobo J, Fernández-Sampedro M, Del Toro MD, Guío L, Praena J, Bahamonde A, Riera M, Esteban J, Baraia-Etxaburu JM, Martínez-Alvarez J, Jover-Sáenz A, Dueñas C, Ramos A, Sobrino B, Euba G, Morata L, Pigrau C, Horcajada JP, Coll P, Crusi X, Ariza J; REIPI (Spanish Network for Research in Infectious Disease) Group for the Study of Prosthetic Joint Infections / GEIO (Group for the Study of Osteoarticular Infections), SEIMC (Spanish Society of Infectious Diseases and Clinical Microbiolo.

J Clin Med. 2019 May 13;8(5). pii: E673. doi: 10.3390/jcm8050673.

5.

Corrigendum to "Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration" [International Journal of Antimicrobial Agents 53(3) (2019) 294-301].

Papadopoulos A, Ribera A, Mavrogenis AF, Rodriguez-Pardo D, Bonnet E, JoséSalles M, Dolores Del Toro M, Nguyen S, Blanco-García A, Skaliczki G, Soriano A, Benito N, Petersdorf S, Pasticci MB, Tattevin P, Tufan ZK, Chan M, O'Connell N, Pantazis N, Kyprianou A, Pigrau C, Megaloikonomos PD, Senneville E, Ariza J, Papagelopoulos PJ, Giannitsioti E; ESCMID Study Group for Implant-Associated Infections (ESGIAI).

Int J Antimicrob Agents. 2019 Apr;53(4):538-539. doi: 10.1016/j.ijantimicag.2019.03.005. Epub 2019 Mar 23. No abstract available.

PMID:
30910479
6.

Acute spinal implant infection treated with debridement: does extended antibiotic treatment improve the prognosis?

Bosch-Nicolau P, Rodríguez-Pardo D, Pigrau C, Pellisé F, Haddad S, Lung M, Almirante B.

Eur J Clin Microbiol Infect Dis. 2019 May;38(5):951-958. doi: 10.1007/s10096-019-03537-8. Epub 2019 Mar 23.

PMID:
30904996
7.

Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.

Morata L, Cobo J, Fernández-Sampedro M, Guisado Vasco P, Ruano E, Lora-Tamayo J, Sánchez Somolinos M, González Ruano P, Rico Nieto A, Arnaiz A, Estébanez Muñoz M, Jiménez-Mejías ME, Lozano Serrano AB, Múñez E, Rodriguez-Pardo D, Argelich R, Arroyo A, Barbero JM, Cuadra F, Del Arco A, Del Toro MD, Guio L, Jimenez-Beatty D, Lois N, Martin O, Martínez Alvarez RM, Martinez-Marcos FJ, Porras L, Ramírez M, Vergas García J, Soriano A.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02280-18. doi: 10.1128/AAC.02280-18. Print 2019 May.

PMID:
30858217
8.

Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.

Papadopoulos A, Ribera A, Mavrogenis AF, Rodriguez-Pardo D, Bonnet E, Salles MJ, Dolores Del Toro M, Nguyen S, Blanco-García A, Skaliczki G, Soriano A, Benito N, Petersdorf S, Pasticci MB, Tattevin P, Tufan ZK, Chan M, O'Connell N, Pantazis N, Kyprianou A, Pigrau C, Megaloikonomos PD, Senneville E, Ariza J, Papagelopoulos PJ, Giannitsioti E; ESCMID Study Group for Implant-Associated Infections (ESGIAI).

Int J Antimicrob Agents. 2019 Mar;53(3):294-301. doi: 10.1016/j.ijantimicag.2018.10.018. Epub 2018 Nov 3. Erratum in: Int J Antimicrob Agents. 2019 Apr;53(4):538-539.

PMID:
30395988
9.

Early oral switch to linezolid for low-risk patients with Staphylococcus aureus bloodstream infections: a propensity-matched cohort study.

Willekens R, Puig-Asensio M, Ruiz-Camps I, Larrosa MN, González-López JJ, Rodríguez-Pardo D, Fernández-Hidalgo N, Pigrau C, Almirante B.

Clin Infect Dis. 2018 Oct 23. doi: 10.1093/cid/ciy916. [Epub ahead of print]

PMID:
30351401
10.

Teicoplanin for treating enterococcal infective endocarditis: A retrospective observational study from a referral centre in Spain.

Escolà-Vergé L, Fernández-Hidalgo N, Rodríguez-Pardo D, Pigrau C, González-López JJ, Bartolomé R, Almirante B.

Int J Antimicrob Agents. 2019 Feb;53(2):165-170. doi: 10.1016/j.ijantimicag.2018.10.003. Epub 2018 Oct 10.

PMID:
30315920
11.

Prognosis of Clostridium difficile infection in adult oncohaematological patients: experience from a large prospective observational study.

Larrainzar-Coghen T, Rodríguez-Pardo D, Barba P, Aguilar-Company J, Rodríguez V, Roig G, Ferrer C, Ruiz-Camps I, Almirante B.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2075-2082. doi: 10.1007/s10096-018-3341-4. Epub 2018 Aug 2.

PMID:
30073433
12.

Native vertebral osteomyelitis in aged patients: distinctive features. An observational cohort study.

Aguilar-Company J, Pigrau C, Fernández-Hidalgo N, Rodríguez-Pardo D, Falcó V, Lung M, Pellisé F, Almirante B.

Infection. 2018 Oct;46(5):679-686. doi: 10.1007/s15010-018-1177-6. Epub 2018 Jul 12.

PMID:
30003490
13.

Candida periprosthetic joint infection: A rare and difficult-to-treat infection.

Escolà-Vergé L, Rodríguez-Pardo D, Lora-Tamayo J, Morata L, Murillo O, Vilchez H, Sorli L, Carrión LG, Barbero JM, Palomino-Nicás J, Bahamonde A, Jover-Sáenz A, Benito N, Escudero R, Sampedro MF, Vidal RP, Gómez L, Corona PS, Almirante B, Ariza J, Pigrau C; Study Group on Osteoarticular Infections of the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIO-SEIMC), and the Spanish Network for Research in Infectious Pathology (REIPI).

J Infect. 2018 Aug;77(2):151-157. doi: 10.1016/j.jinf.2018.03.012. Epub 2018 May 8.

PMID:
29746950
14.

The impact of deep surgical site infection on surgical outcomes after posterior adult spinal deformity surgery: a matched control study.

Haddad S, Núñez-Pereira S, Pigrau C, Rodríguez-Pardo D, Vila-Casademunt A, Alanay A, Acaroglu ER, Kleinstueck FS, Obeid I, Perez-Grueso FJS, Pellisé F; European Spine Study Group.

Eur Spine J. 2018 Oct;27(10):2518-2528. doi: 10.1007/s00586-018-5583-3. Epub 2018 May 4.

PMID:
29728924
15.

Secular trends in the epidemiology of Clostridium difficile infection (CDI) at a tertiary care hospital in Barcelona, 2006-2015: A prospective observational study.

Larrainzar-Coghen T, Rodríguez-Pardo D, Fernández-Hidalgo N, Puig-Asensio M, Pigrau C, Ferrer C, Rodríguez V, Bartolomé R, Campany D, Almirante B.

Anaerobe. 2018 Jun;51:54-60. doi: 10.1016/j.anaerobe.2018.04.002. Epub 2018 Apr 12.

PMID:
29655966
16.

Acute periprosthetic joint infection due to Fusobacterium nucleatum in a non-immunocompromised patient. Failure using a Debridement, Antibiotics + Implant retention approach.

Corona PS, Lung M, Rodriguez-Pardo D, Pigrau C, Soldado F, Amat C, Carrera L.

Anaerobe. 2018 Feb;49:116-120. doi: 10.1016/j.anaerobe.2017.12.010. Epub 2018 Jan 5.

PMID:
29307651
17.

The changing epidemiology of spinal tuberculosis: the influence of international immigration in Catalonia, 1993-2014.

Peghin M, Rodriguez-Pardo D, Sanchez-Montalva A, Pellisé F, Rivas A, Tortola T, Aguilar J, Almirante B, Pigrau C.

Epidemiol Infect. 2017 Jul;145(10):2152-2160. doi: 10.1017/S0950268817000863. Epub 2017 May 18.

PMID:
28516818
18.

The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study.

Lora-Tamayo J, Senneville É, Ribera A, Bernard L, Dupon M, Zeller V, Li HK, Arvieux C, Clauss M, Uçkay I, Vigante D, Ferry T, Iribarren JA, Peel TN, Sendi P, Miksic NG, Rodríguez-Pardo D, Del Toro MD, Fernández-Sampedro M, Dapunt U, Huotari K, Davis JS, Palomino J, Neut D, Clark BM, Gottlieb T, Trebše R, Soriano A, Bahamonde A, Guío L, Rico A, Salles MJC, Pais MJG, Benito N, Riera M, Gómez L, Aboltins CA, Esteban J, Horcajada JP, O'Connell K, Ferrari M, Skaliczki G, Juan RS, Cobo J, Sánchez-Somolinos M, Ramos A, Giannitsioti E, Jover-Sáenz A, Baraia-Etxaburu JM, Barbero JM, Choong PFM, Asseray N, Ansart S, Moal GL, Zimmerli W, Ariza J; Group of Investigators for Streptococcal Prosthetic Joint Infection .

Clin Infect Dis. 2017 Jun 15;64(12):1742-1752. doi: 10.1093/cid/cix227.

19.

[Evaluation of clinical evidence for dalbavancin].

Rodríguez-Pardo D.

Enferm Infecc Microbiol Clin. 2017 Jan;35 Suppl 1:33-37. doi: 10.1016/S0213-005X(17)30033-2. Spanish.

PMID:
28129819
20.

Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

de Cueto M, Aliaga L, Alós JI, Canut A, Los-Arcos I, Martínez JA, Mensa J, Pintado V, Rodriguez-Pardo D, Yuste JR, Pigrau C.

Enferm Infecc Microbiol Clin. 2017 May;35(5):314-320. doi: 10.1016/j.eimc.2016.11.005. Epub 2016 Dec 23. English, Spanish.

PMID:
28017477
21.

Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study.

Benito N, Franco M, Ribera A, Soriano A, Rodriguez-Pardo D, Sorlí L, Fresco G, Fernández-Sampedro M, Dolores Del Toro M, Guío L, Sánchez-Rivas E, Bahamonde A, Riera M, Esteban J, Baraia-Etxaburu JM, Martínez-Alvarez J, Jover-Sáenz A, Dueñas C, Ramos A, Sobrino B, Euba G, Morata L, Pigrau C, Coll P, Mur I, Ariza J; REIPI (Spanish Network for Research in Infectious Disease) Group for the Study of Prosthetic Joint Infections.

Clin Microbiol Infect. 2016 Aug;22(8):732.e1-8. doi: 10.1016/j.cmi.2016.05.004. Epub 2016 May 13.

22.

Effectiveness of sequential intravenous-to-oral antibiotic switch therapy in hospitalized patients with gram-positive infection: the SEQUENCE cohort study.

Rodriguez-Pardo D, Pigrau C, Campany D, Diaz-Brito V, Morata L, de Diego IC, Sorlí L, Iftimie S, Pérez-Vidal R, García-Pardo G, Larrainzar-Coghen T, Almirante B.

Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1269-76. doi: 10.1007/s10096-016-2661-5. Epub 2016 May 14.

23.

Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis.

Aguilar-Company J, Los-Arcos I, Pigrau C, Rodríguez-Pardo D, Larrosa MN, Rodríguez-Garrido V, Sihuay-Diburga D, Almirante B.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4398-400. doi: 10.1128/AAC.00447-16. Print 2016 Jul.

24.

Teicoplanin - An old new treatment for enterococcal prosthetic joint infections.

López-Sánchez C, Rodríguez-Pardo D, Pigrau C, Corona PS, Amat C, Lung M, Carrera L, Almirante B.

J Infect. 2016 Jun;72(6):764-766. doi: 10.1016/j.jinf.2016.03.002. Epub 2016 Mar 11. No abstract available.

PMID:
26976525
25.

Increased infection risk after hip hemiarthroplasty in institutionalized patients with proximal femur fracture.

Gallardo-Calero I, Larrainzar-Coghen T, Rodriguez-Pardo D, Pigrau C, Sánchez-Raya J, Amat C, Lung M, Carrera L, Corona PS.

Injury. 2016 Apr;47(4):872-6. doi: 10.1016/j.injury.2015.12.032. Epub 2016 Jan 7.

PMID:
26857632
26.

First recurrence of Clostridium difficile infection: clinical relevance, risk factors, and prognosis.

Larrainzar-Coghen T, Rodriguez-Pardo D, Puig-Asensio M, Rodríguez V, Ferrer C, Bartolomé R, Pigrau C, Fernández-Hidalgo N, Pumarola T, Almirante B.

Eur J Clin Microbiol Infect Dis. 2016 Mar;35(3):371-8. doi: 10.1007/s10096-015-2549-9. Epub 2016 Jan 11.

PMID:
26753991
27.

Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis.

Los-Arcos I, Pigrau C, Rodríguez-Pardo D, Fernández-Hidalgo N, Andreu A, Larrosa N, Almirante B.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1854-8. doi: 10.1128/AAC.02611-15.

28.

Health care associated hematogenous pyogenic vertebral osteomyelitis: a severe and potentially preventable infectious disease.

Pigrau C, Rodríguez-Pardo D, Fernández-Hidalgo N, Moretó L, Pellise F, Larrosa MN, Puig M, Almirante B.

Medicine (Baltimore). 2015 Jan;94(3):e365. doi: 10.1097/MD.0000000000000365.

29.

An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future.

Rodríguez-Pardo D, Pigrau C, Corona PS, Almirante B.

Expert Rev Anti Infect Ther. 2015 Feb;13(2):249-65. doi: 10.1586/14787210.2015.999669. Review.

PMID:
25578886
30.

High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: a comparative study.

Lora-Tamayo J, Parra-Ruiz J, Rodríguez-Pardo D, Barberán J, Ribera A, Tornero E, Pigrau C, Mensa J, Ariza J, Soriano A.

Diagn Microbiol Infect Dis. 2014 Sep;80(1):66-71. doi: 10.1016/j.diagmicrobio.2014.05.022. Epub 2014 Jun 5.

PMID:
24996840
31.

Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study.

Tornero E, Senneville E, Euba G, Petersdorf S, Rodriguez-Pardo D, Lakatos B, Ferrari MC, Pilares M, Bahamonde A, Trebse R, Benito N, Sorli L, del Toro MD, Baraiaetxaburu JM, Ramos A, Riera M, Jover-Sáenz A, Palomino J, Ariza J, Soriano A; European Society Group of Infections on Artificial Implants (ESGIAI).

Clin Microbiol Infect. 2014 Nov;20(11):1219-24. doi: 10.1111/1469-0691.12721.

32.

Impact of prompt catheter withdrawal and adequate antimicrobial therapy on the prognosis of hospital-acquired parenteral nutrition catheter-related bacteraemia.

Rodríguez-Pardo D, Almirante B, Fernández-Hidalgo N, Pigrau C, Ferrer C, Planes AM, Alcaraz R, Burgos R, Pahissa A.

Clin Microbiol Infect. 2014 Nov;20(11):1205-10. doi: 10.1111/1469-0691.12703. Epub 2014 Jul 15.

33.

Antibiotic susceptibility in gram-positive chronic joint arthroplasty infections: increased aminoglycoside resistance rate in patients with prior aminoglycoside-impregnated cement spacer use.

Corona PS, Espinal L, Rodríguez-Pardo D, Pigrau C, Larrosa N, Flores X.

J Arthroplasty. 2014 Aug;29(8):1617-21. doi: 10.1016/j.arth.2014.03.029. Epub 2014 Mar 29.

PMID:
24798194
34.

Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study.

Rodríguez-Pardo D, Pigrau C, Lora-Tamayo J, Soriano A, del Toro MD, Cobo J, Palomino J, Euba G, Riera M, Sánchez-Somolinos M, Benito N, Fernández-Sampedro M, Sorli L, Guio L, Iribarren JA, Baraia-Etxaburu JM, Ramos A, Bahamonde A, Flores-Sánchez X, Corona PS, Ariza J; REIPI Group for the Study of Prosthetic Infection.

Clin Microbiol Infect. 2014 Nov;20(11):O911-9. doi: 10.1111/1469-0691.12649. Epub 2014 Jun 14.

35.

Postoperative urinary tract infection and surgical site infection in instrumented spinal surgery: is there a link?

Núñez-Pereira S, Rodríguez-Pardo D, Pellisé F, Pigrau C, Bagó J, Villanueva C, Cáceres E.

Clin Microbiol Infect. 2014 Aug;20(8):768-73. doi: 10.1111/1469-0691.12527. Epub 2014 Feb 20.

36.

Implant survival after deep infection of an instrumented spinal fusion.

Núñez-Pereira S, Pellisé F, Rodríguez-Pardo D, Pigrau C, Bagó J, Villanueva C, Cáceres E.

Bone Joint J. 2013 Aug;95-B(8):1121-6. doi: 10.1302/0301-620X.95B8.30784.

PMID:
23908430
37.

[Reply to «infections caused by Clostridium difficile. Addendum»].

Rodríguez-Pardo D, Mirelis B, Navarro F.

Enferm Infecc Microbiol Clin. 2013 Oct;31(8):558. doi: 10.1016/j.eimc.2013.04.020. Epub 2013 Jul 6. Spanish. No abstract available.

PMID:
23838212
38.

Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria.

Cobo J, Lora-Tamayo J, Euba G, Jover-Sáenz A, Palomino J, del Toro MD, Rodríguez-Pardo D, Riera M, Ariza J; Red Española para la Investigación en Patología Infecciosa (REIPI).

Diagn Microbiol Infect Dis. 2013 May;76(1):93-8. doi: 10.1016/j.diagmicrobio.2013.02.019. Epub 2013 Mar 27.

PMID:
23541692
39.

Long-term follow-up of jaw osteomyelitis associated with bisphosphonate use in a tertiary-care center.

Pigrau-Serrallach C, Cabral-Galeano E, Almirante-Gragera B, Sordé-Masip R, Rodriguez-Pardo D, Fernandez-Hidalgo N, Larrosa-Escartín N, Bescos-Atín S, Pahissa-Berga A.

Enferm Infecc Microbiol Clin. 2014 Jan;32(1):18-22. doi: 10.1016/j.eimc.2013.01.007. Epub 2013 Mar 6.

PMID:
23473675
40.

Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain.

Rodríguez-Pardo D, Almirante B, Bartolomé RM, Pomar V, Mirelis B, Navarro F, Soriano A, Sorlí L, Martínez-Montauti J, Molins MT, Lung M, Vila J, Pahissa A; Barcelona Clostridium difficile Study Group.

J Clin Microbiol. 2013 May;51(5):1465-73. doi: 10.1128/JCM.03352-12. Epub 2013 Feb 27.

41.

[Infections caused by Clostridium difficile].

Rodríguez-Pardo D, Mirelis B, Navarro F.

Enferm Infecc Microbiol Clin. 2013 Apr;31(4):254-63. doi: 10.1016/j.eimc.2012.12.010. Epub 2013 Feb 12. Spanish.

PMID:
23411363
42.

Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study.

Len O, Rodríguez-Pardo D, Gavaldà J, Aguado JM, Blanes M, Borrell N, Bou G, Carratalà J, Cisneros JM, Fortún J, Gurguí M, Montejo M, Cervera C, Muñoz P, Asensio A, Torre-Cisneros J, Pahissa A; Spanish Research Network for the Study of Infection in Transplantation.

Transpl Int. 2012 Dec;25(12):1275-81. doi: 10.1111/j.1432-2277.2012.01568.x. Epub 2012 Oct 5.

43.

A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.

Lora-Tamayo J, Murillo O, Iribarren JA, Soriano A, Sánchez-Somolinos M, Baraia-Etxaburu JM, Rico A, Palomino J, Rodríguez-Pardo D, Horcajada JP, Benito N, Bahamonde A, Granados A, del Toro MD, Cobo J, Riera M, Ramos A, Jover-Sáenz A, Ariza J; REIPI Group for the Study of Prosthetic Infection.

Clin Infect Dis. 2013 Jan;56(2):182-94. doi: 10.1093/cid/cis746. Epub 2012 Aug 31.

PMID:
22942204
44.

Bone and joint tuberculosis.

Pigrau-Serrallach C, Rodríguez-Pardo D.

Eur Spine J. 2013 Jun;22 Suppl 4:556-66. doi: 10.1007/s00586-012-2331-y. Epub 2012 Jun 19. Review.

45.

Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections.

Corona Pérez-Cardona PS, Barro Ojeda V, Rodriguez Pardo D, Pigrau Serrallach C, Guerra Farfán E, Amat Mateu C, Flores Sanchez X.

J Antimicrob Chemother. 2012 Jul;67(7):1749-54. doi: 10.1093/jac/dks119. Epub 2012 Apr 17.

PMID:
22511636
46.

Individualized antibiotic prophylaxis reduces surgical site infections by gram-negative bacteria in instrumented spinal surgery.

Núñez-Pereira S, Pellisé F, Rodríguez-Pardo D, Pigrau C, Sánchez JM, Bagó J, Villanueva C, Cáceres E.

Eur Spine J. 2011 Aug;20 Suppl 3:397-402. doi: 10.1007/s00586-011-1906-3. Epub 2011 Jul 26.

47.

Data mining validation of fluconazole breakpoints established by the European Committee on Antimicrobial Susceptibility Testing.

Cuesta I, Bielza C, Larrañaga P, Cuenca-Estrella M, Laguna F, Rodriguez-Pardo D, Almirante B, Pahissa A, Rodríguez-Tudela JL.

Antimicrob Agents Chemother. 2009 Jul;53(7):2949-54. doi: 10.1128/AAC.00081-09. Epub 2009 May 11.

48.

Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.

Rodríguez-Tudela JL, Almirante B, Rodríguez-Pardo D, Laguna F, Donnelly JP, Mouton JW, Pahissa A, Cuenca-Estrella M.

Antimicrob Agents Chemother. 2007 Oct;51(10):3599-604. Epub 2007 Jul 23.

49.

Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.

Ribera E, Rodríguez-Pardo D, Rubio M, Soler A, Pedrol E, Blanco JL, González A, Crespo M, Falcó V, Ocaña I, Deig E, Miró JM, Pahissa A.

Antivir Ther. 2005;10(5):605-14.

PMID:
16152754
50.

[Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection].

Vallejo Camazón N, Rodríguez Pardo D, Sánchez Hidalgo A, Tornos Mas MP, Ribera E, Soler Soler J.

Rev Esp Cardiol. 2002 Aug;55(8):878-81. Spanish.

Supplemental Content

Loading ...
Support Center